sodium-glucose cotransporter 2 inhibitorsglucagon-like peptide 1 receptor agonistsType 2 diabeteschronic kidney diseasecardiovascular diseaseretinopathy
…ugh sustained remission is untested. Recently introduced drugs (sodium-glucose cotransporter 2 inhibitors and newer glucagon-like peptide 1 receptor agonists) offer prom…